DAVID POPLACK to Cell Line
This is a "connection" page, showing publications DAVID POPLACK has written about Cell Line.
Connection Strength
0.057
-
Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Cancer Res. 1987 Nov 15; 47(22):5932-4.
Score: 0.013
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
Score: 0.012
-
Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Cancer Res. 1985 Sep; 45(9):4156-61.
Score: 0.011
-
Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. Biochem Pharmacol. 1995 Apr 18; 49(8):1069-78.
Score: 0.005
-
Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 1989 May 15; 73(7):1968-72.
Score: 0.003
-
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989; 28(1):59-66.
Score: 0.003
-
Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Isr J Med Sci. 1988 Sep-Oct; 24(9-10):477-82.
Score: 0.003
-
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan; 84(1):265-9.
Score: 0.003
-
ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity. Clin Exp Immunol. 1979 Mar; 35(3):447-53.
Score: 0.002
-
A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Res. 1975 Dec; 35(12):3715-20.
Score: 0.001